Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a customer in China who has previously evaluated the product. The value amounts to approximately SEK 2 million. The customer is a pharmaceutical manufacturer that has evaluated NLAB Saga® on a small scale and has now placed an order for production.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.88 SEK | +1.03% |
|
+4.26% | -43.46% |
20/06 | Nanologica Secures SEK2 Million Order for Silica Product in China | MT |
20/06 | Nanologica Receives Order for NLAB Saga Valued to approximately SEK 2 Million | CI |
1st Jan change | Capi. | |
---|---|---|
-43.46% | 2.42Cr | |
-3.57% | 3.71TCr | |
-27.86% | 1.93TCr | |
-28.66% | 1.09TCr | |
+34.03% | 916.55Cr | |
-22.07% | 870.57Cr | |
-22.07% | 496.95Cr | |
-44.37% | 416.93Cr | |
-29.96% | 335.18Cr | |
+26.76% | 266.03Cr |
- Stock Market
- Equities
- NICA Stock
- News Nanologica AB
- Nanologica Receives Order for NLAB Saga Valued to approximately SEK 2 Million